The influence of cimetidine on the pharmacokinetics of the enantiomers of verapamil in the dog during multiple oral dosing
โ Scribed by L.M. JOHNSON; S.M. LANKFORD; S.A. BAI
- Book ID
- 114744947
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 596 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0140-7783
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The kinetics and negative dromotropic action of intravenous (1 mg kg-') and oral (5 mg kg-') diltiazem were studied in dogs after acute doses, after treatment for 3 days with oral diltiazem (5 mg kg-I, t.i.d.), and after 3 days' treatment with oral diltiazem (5 mg kg-' t.i.d.) and cimetidine (200mg
Reboxetine, (RS)-2-[(RS)-alpha-(2-ethoxyphenoxy)benzyl]morpholine methanesulphonate, is a racemic compound and consists of a mixture of the (R,R)- and (S,S)-enantiomers. The pharmacokinetics of reboxetine enantiomers were determined in a crossover study in three male beagle dogs. Each animal receive
Verapamil is a chiral calcium channel blocking drug which is useful clinically as the racemate in treating hypertension and arrhythmia. The published pharmacokinetic data for verapamil enantiomers in the rat model are limited. Utilizing a stereospeciยฎc highperformance liquid chromatographic (HPLC) a